Copyright
©2013 Baishideng Publishing Group Co.
World J Immunol. Nov 27, 2013; 3(3): 54-61
Published online Nov 27, 2013. doi: 10.5411/wji.v3.i3.54
Published online Nov 27, 2013. doi: 10.5411/wji.v3.i3.54
Table 2 Clinical characteristics of hepatitis C patients aged ≥ 65 years and treated with standard of care
Total (n= 196) | Male (n= 104) | Female (n= 92) | P value1 | |
Age (yr) | 67.8 ± 2.5 | 68.1 ± 2.6 | 67.4 ± 2.4 | |
Gender (male/female) | 104/92 | 104/0 | 0/92 | |
HCV viral load (high/low/unknown) | 185/7/4 | 6/2/1996 | 1/2/1989 | 0.169 |
HCV genotypes 1/2 | 164/32 | Nov-93 | 71/21 | 0.033 |
Treatment-naïve (yes/no/unknown) | 108/87/1 | 55/48/1 | 52/39/1 | 0.704 |
ALT (IU/L) | 61.3 ± 50.7 | 70.1 ± 57.1 | 51.4 ± 40.3 | 0.010 |
White blood cells (/μL) | 4940 ± 1490 | 5160 ± 1670 | 4690 ± 1210 | 0.027 |
Neutrophils (/μL) | 2660 ± 1080 | 2790 ± 1270 | 2530 ± 830 | 0.096 |
Hemoglobin (g/dL) | 13.7 ± 1.5 | 14.1 ± 1.6 | 13.2 ± 1.3 | 0.000 |
Platelets (× 104/μL) | 15.1 ± 4.7 | 15.0 ± 4.8 | 15.4 ± 4.6 | 0.553 |
Peg-IFN α - 2a / Peg-IFN α - 2b | 86/110 | 41/63 | 45/47 | 0.233 |
-
Citation: Kanda T, Nakamoto S, Wu S, Yokosuka O. Role of
IL28B genotype in older hepatitis C virus-infected patients. World J Immunol 2013; 3(3): 54-61 - URL: https://www.wjgnet.com/2219-2824/full/v3/i3/54.htm
- DOI: https://dx.doi.org/10.5411/wji.v3.i3.54